Cardiokol

Company Overview

Snapshot

Founded in August 2017 by Alon Goren, Eli Attar, and Pini Sabach, Cardiokol operates with 1–10 employees. The company has raised $8M across two funding rounds.

Business overview

Cardiokol is a digital telehealth company focused on developing voice-based markers and methods for the large-scale monitoring and screening of heart rhythm disorders. The company leverages proprietary technology integrated into various speech platforms, including landlines, smartphones, smart speakers, and voice assistants. Cardiokol provides low-cost, long-term, and user-friendly monitoring solutions primarily for at-risk populations, such as older adults (65+), operating within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Patient Remote Monitoring.

Strategic signal

In July 2026, Cardiokol, an AI startup specializing in stroke detection technology, sought court protection. This development indicates a significant operational challenge for the company, signaling potential financial distress or a strategic restructuring to navigate its future trajectory within the competitive digital health market.

Company Intelligence Q&A

What is Cardiokol's core technology?

Cardiokol develops proprietary voice-based markers and methods for monitoring and screening heart rhythm disorders. This technology is implemented across various speech platforms, including landlines, smartphones, smart speakers, and voice assistants.

When was Cardiokol founded and by whom?

Cardiokol was founded in August 2017 by Alon Goren, Eli Attar, and Pini Sabach.

What was a significant recent development for Cardiokol?

In July 2026, Cardiokol, an AI startup focused on stroke detection technology, sought court protection.

Which program did Cardiokol join in November 2021?

In November 2021, Cardiokol joined Bayer's G4A program, which supports digital health pioneers.